• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Shilpa Medicare Limited — Updates, 28-01-2026: Press Release

    28-01-2026 | 02:33 pm

    Shilpa Medicare's subsidiary, Shilpa Biologicals, with mAbTree Biologics, secured US FDA Orphan Drug Designation for its biologic product targeting rare blood cancers (ET & PV). This accelerates development and offers significant market exclusivity potential upon approval.

    No comments yet. Be the first to comment!

    All announcements from Shilpa Medicare Limited